Nesfatin-1 Level in Patients With Type 2 Diabetes, Insulin Resistance and Obesity

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This research was planned to determine the level of nesfatin-1, known as satiety hormone, in type 2 diabetes, insulin diabetes and obesity patients and to determine whether there is a relationship between patients\' energy intake levels. Additionally, it was aimed to evaluate the relationship between patients\' nesfatin-1 values and serum glucose, insulin, lipid concentrations.
Epistemonikos ID: 5c30a51fe3fd2120871035cf33947920b402727b
First added on: May 07, 2024